Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study.

A BayleL BelcaidM AldeaD VasseurF PeyraudC NicotraA GeraudM SakkalL SeknaziL CerboneF Blanc-DurandJ HadouxF MoseleM TagliamentoA Bernard-TessierB VerretC SmolenschiR ClodionN AugerP Martin RomanoA GazzahM Ngo CamusJ MicolO CaronA HollebecqueY LoriotB BesseL LacroixE RouleauS PonceJ C SoriaF BarlesiF AndreA Italiano

Published in: Annals of oncology : official journal of the European Society for Medical Oncology (2023)

CTDNA sequencing with a large panel is an efficient approach to match advanced cancer patients with targeted therapies.

Keyphrases

circulating tumor
advanced cancer
cell free
circulating tumor cells
palliative care
single cell
quality improvement